المؤلفون: H Askelund Sævereid, M Husain, SC Bain, JFE Mann, MA Nauck, NR Poulter, B Goldman, A Bloch Thomsen, SP Marso

المصدر: Diabetes – Nicht nur eine Typ-Frage – www.diabeteskongress.de.

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::5b02536aaf59687b987619d91216c038
https://doi.org/10.1055/s-0039-1688301

المؤلفون: Sp, Marso, Gh, Daniels, Brown-Frandsen K, Kristensen P, Jf, Mann, Ma, Nauck, Se, Nissen, Pocock S, Nr, Poulter, Ls, Ravn, Wm, Steinberg, Stockner M, Zinman B, Rm, Bergenstal, Jb, Buse, Leader, Steering Committee, Leader, Trial Investigators

المصدر: Europe PubMed Central

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1edfe32ff751f8430bd907f8c3dd33ed
http://europepmc.org/abstract/med/27295427

المؤلفون: Yeh RW; Beth Israel Deaconess Medical Center, Boston, Massachusetts., Shlofmitz R; St Francis Hospital, Roslyn, New York., Moses J; Columbia University Irving Medical Center/NewYork-Presbyterian Hospital and the Cardiovascular Research Foundation, New York., Bachinsky W; University of Pittsburgh Medical Center, Harrisburg, Pennsylvania., Dohad S; Cedars Sinai Medical Center, Los Angeles, California., Rudick S; Lindner Center for Research and Education at Christ Hospital, Cincinnati, Ohio., Stoler R; Baylor Scott & White Heart and Vascular Hospital, Dallas, Texas., Jefferson BK; HCA Tristar Centennial Medical Center, Nashville, Tennessee., Nicholson W; Emory University Hospital, Atlanta, Georgia., Altman J; St Anthony Hospital, Denver, Colorado., Bateman C; South Denver Cardiology, Littleton, Colorado., Krishnaswamy A; Cleveland Clinic Foundation, Cleveland, Ohio., Grantham JA; St Luke's Hospital of Kansas City, Kansas City, Missouri., Zidar FJ; Austin Heart, Austin, Texas., Marso SP; Overland Park Regional Medical Center, Overland Park, Kansas., Tremmel JA; Stanford University Medical Center, Stanford, California., Grines C; Northside Hospital Cardiovascular Institute, Atlanta, Georgia., Ahmed MI; University of Alabama at Birmingham., Latib A; Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York., Tehrani B; The Inova Schar Heart and Vascular Institute, Falls Church, Virginia., Abbott JD; Lifespan Cardiovascular Institute, Rhode Island Hospital, Providence., Batchelor W; The Inova Schar Heart and Vascular Institute, Falls Church, Virginia., Underwood P; Boston Scientific Corp, Marlborough, Massachusetts., Allocco DJ; Boston Scientific Corp, Marlborough, Massachusetts., Kirtane AJ; Columbia University Irving Medical Center/NewYork-Presbyterian Hospital and the Cardiovascular Research Foundation, New York.

مؤلفون مشاركون: AGENT IDE Investigators

المصدر: JAMA [JAMA] 2024 Mar 26; Vol. 331 (12), pp. 1015-1024.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE

مواضيع طبية MeSH: Coronary Restenosis*/etiology , Coronary Restenosis*/therapy , Myocardial Infarction*, Female ; Humans ; Aged ; Paclitaxel ; Stents ; Treatment Outcome ; Death

المؤلفون: Basir MB; Henry Ford Hospital Detroit MI., Lemor A; University of Mississippi Jackson MS., Gorgis S; Henry Ford Hospital Detroit MI., Patel KC; St. Joseph Mercy Oakland MI., Kolski BC; St. Joseph Hospital Orange Orange CA., Bharadwaj AS; Loma Linda University Medical Center Loma Linda CA., Todd JW; Fort Sanders Regional Medical Center Fort Sanders TN., Tehrani BN; Inova Fairfax Hospital Fairfax VA., Truesdell AG; Inova Fairfax Hospital Fairfax VA., Lasorda DM; Allegheny General Hospital Pittsburg PA., Lalonde TA; Ascension St. John Hospital Detroit MI., Kaki A; Ascension St. John Hospital Detroit MI., Schrieber TL; Ascension St. John Hospital Detroit MI., Patel NC; Lehigh Valley Hospital Allentown PA., Senter SR; Washington Regional Medical Center Washington AK., Gelormini JL; Mercy Hospital Buffalo NY., Marso SP; Overland Park Regional Medical Center Overland Park KS., Rahman AM; Parkwest Medical Center Knoxville TN., Federici RE; Presbyterian Hospital Albuquerque NM., Wilkins CE; San Juan Regional Medical Center San Juan NM., Thomas McRae A 3rd; TriStar Centennial Medical Center Nashville TN., Nsair A; Ronald Reagan UCLA Medical Center Los Angeles CA., Caputo CP; North Florida Regional Medical Center Gainesville FL., Khuddus MA; North Florida Regional Medical Center Gainesville FL., Chahin JJ; Excela Health Westmoreland Hospital Greensburg PA., Dupont AG; Northside Cardiovascular Institute Atlanta GA., Goldsweig AM; Baystate Medical Center Springfield MA., Lim MJ; Hackensack Medical Center Hackensack NJ., Kapur NK; Tufts Medical Center Boston MA., Wohns DHW; Spectrum Health Butterworth Hospital Grand Rapids MI., Zhou Y; Henry Ford Hospital Detroit MI., Hacala MJ; Henry Ford Hospital Detroit MI., O'Neill WW; Henry Ford Hospital Detroit MI.

المصدر: Journal of the American Heart Association [J Am Heart Assoc] 2023 Dec 05; Vol. 12 (23), pp. e031401. Date of Electronic Publication: 2023 Nov 28.

نوع المنشور: Clinical Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2047-9980 (Electronic) Linking ISSN: 20479980 NLM ISO Abbreviation: J Am Heart Assoc Subsets: MEDLINE

مواضيع طبية MeSH: Heart-Assist Devices* , Myocardial Infarction*/complications , Myocardial Infarction*/therapy, Aged ; Female ; Humans ; Male ; Middle Aged ; Lactic Acid ; Shock, Cardiogenic/diagnosis ; Shock, Cardiogenic/etiology ; Shock, Cardiogenic/therapy ; Treatment Outcome

المؤلفون: Lingvay I; Department of Internal Medicine/Endocrinology and Department of Population and Data Sciences, UT Southwestern Medical Center, Dallas, Texas, USA., Brown-Frandsen K; Novo Nordisk A/S, Søborg, Denmark., Colhoun HM; Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK., Deanfield J; Farr Institute of Health Informatics Research at London, London, UK and National Institute for Cardiovascular Outcomes Research, University College London, London, UK., Emerson SS; Department of Biostatistics, University of Washington, Seattle, Washington, USA., Esbjerg S; Novo Nordisk A/S, Søborg, Denmark., Hardt-Lindberg S; Novo Nordisk A/S, Søborg, Denmark., Hovingh GK; Novo Nordisk A/S, Søborg, Denmark., Kahn SE; Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle, Washington, USA., Kushner RF; Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Lincoff AM; Cleveland Clinic Coordinating Center for Clinical Research (C5Research) and Department of Cardiovascular Medicine, Cleveland, Ohio, USA., Marso SP; HCA Midwest Health Heart and Vascular Institute, Kansas City, Missouri, USA., Fries TM; Novo Nordisk A/S, Søborg, Denmark., Plutzky J; Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Ryan DH; Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, Louisiana, USA.

مؤلفون مشاركون: SELECT Study Group

المصدر: Obesity (Silver Spring, Md.) [Obesity (Silver Spring)] 2023 Jan; Vol. 31 (1), pp. 111-122. Date of Electronic Publication: 2022 Dec 10.

نوع المنشور: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 101264860 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1930-739X (Electronic) Linking ISSN: 19307381 NLM ISO Abbreviation: Obesity (Silver Spring) Subsets: MEDLINE

مواضيع طبية MeSH: Cardiovascular Diseases*/epidemiology , Cardiovascular Diseases*/prevention & control , Cardiovascular Diseases*/chemically induced , Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/diagnosis , Myocardial Infarction*/epidemiology , Myocardial Infarction*/prevention & control , Peripheral Arterial Disease*/chemically induced , Stroke*, Female ; Humans ; Male ; Middle Aged ; Hypoglycemic Agents/therapeutic use ; Obesity/complications ; Obesity/drug therapy ; Obesity/chemically induced ; Overweight/complications ; Overweight/drug therapy ; Overweight/chemically induced

المؤلفون: Neeland IJ; University Hospitals Harrington Heart and Vascular Institute and Case Western Reserve University School of Medicine, Cleveland, OH, USA. Electronic address: ian.neeland@uhhospitals.org., Marso SP; HCA Midwest Health, Overland Park, KS, USA., Ayers CR; Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA., Lewis B; Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA., Oslica R; Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA., Francis W; Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, MA, USA., Rodder S; Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA., Pandey A; Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA., Joshi PH; Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.

المصدر: The lancet. Diabetes & endocrinology [Lancet Diabetes Endocrinol] 2021 Sep; Vol. 9 (9), pp. 595-605. Date of Electronic Publication: 2021 Aug 03.

نوع المنشور: Journal Article; Pragmatic Clinical Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: The Lancet, Diabetes & Endocrinology Country of Publication: England NLM ID: 101618821 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-8595 (Electronic) Linking ISSN: 22138587 NLM ISO Abbreviation: Lancet Diabetes Endocrinol Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2/*complications , Diabetes Mellitus, Type 2/*drug therapy , Hypoglycemic Agents/*administration & dosage , Intra-Abdominal Fat/*drug effects , Liraglutide/*administration & dosage , Obesity/*complications , Overweight/*complications, Adult ; Body Composition ; Cardiovascular Diseases ; Double-Blind Method ; Female ; Humans ; Male ; Middle Aged ; Risk Factors ; Treatment Outcome

المؤلفون: Kalra S; Department of Medicine, Einstein Medical Center Philadelphia, Philadelphia, Pennsylvania., Doshi D; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts., Sapontis J; MonashHeart, Monash University, Melbourne, Australia., Kosmidou I; Center for Interventional Vascular Therapy, Columbia University Irving Medical Center, New York, New York.; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York., Kirtane AJ; Center for Interventional Vascular Therapy, Columbia University Irving Medical Center, New York, New York.; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York., Moses JW; Center for Interventional Vascular Therapy, Columbia University Irving Medical Center, New York, New York.; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York.; St. Francis Heart Center, St. Francis Hospital, Roslyn, New York., Riley RF; Heart and Vascular Institute, The Christ Hospital, Cincinnati, Ohio., Jones P; St. Luke's Mid America Heart Institute, Kansas City, Missouri., Nicholson WJ; Department of Medicine, Wellspan York Hospital, York, Pennsylvania., Salisbury AC; St. Luke's Mid America Heart Institute, Kansas City, Missouri.; Department of Medicine, University of Missouri, Kansas City, Missouri., Lombardi WL; Department of Medicine, University of Washington Medical Center, Seattle, Washington., McCabe JM; Department of Medicine, University of Washington Medical Center, Seattle, Washington., Pershad A; Department of Medicine, Banner University Medical Center, Phoenix, Arizona., Hirai T; Department of Medicine, University of Missouri, Kansas City, Missouri., Hakemi E; Center for Interventional Vascular Therapy, Columbia University Irving Medical Center, New York, New York., Russo JJ; Ottawa Heart Institute, Ottawa, Ontario, Canada., Prasad M; Center for Interventional Vascular Therapy, Columbia University Irving Medical Center, New York, New York., Ahmad Y; Center for Interventional Vascular Therapy, Columbia University Irving Medical Center, New York, New York., Hatem R; Department of Medicine, University of Montreal, Montreal, Quebec, Canada., Gkargkoulas F; Center for Interventional Vascular Therapy, Columbia University Irving Medical Center, New York, New York., Spertus JA; Department of Medicine, University of Missouri, Kansas City, Missouri., Wyman RM; Torrance Memorial Medical Center, Torrance, California., Jaffer F; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts., Spaedy A; Boone County Hospital, Columbia, Missouri., Cook S; Peacehealth Sacred Heart Medical Center, Springfield, Oregon., Marso SP; Research Medical Center, Kansas City, Missouri., Nugent K; St. Luke's Mid America Heart Institute, Kansas City, Missouri., Federici R; Presbyterian Health System, Albuquerque, New Mexico., Yeh RW; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Leon MB; Center for Interventional Vascular Therapy, Columbia University Irving Medical Center, New York, New York.; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York., Stone GW; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York.; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Ali ZA; Center for Interventional Vascular Therapy, Columbia University Irving Medical Center, New York, New York.; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York., Parikh MA; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York.; NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York., Maehara A; Center for Interventional Vascular Therapy, Columbia University Irving Medical Center, New York, New York.; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York., Cohen DJ; Department of Medicine, University of Missouri, Kansas City, Missouri., Batres C; Center for Interventional Vascular Therapy, Columbia University Irving Medical Center, New York, New York., Grantham JA; St. Luke's Mid America Heart Institute, Kansas City, Missouri.; Department of Medicine, University of Missouri, Kansas City, Missouri., Karmpaliotis D; Center for Interventional Vascular Therapy, Columbia University Irving Medical Center, New York, New York.; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York.

المصدر: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions [Catheter Cardiovasc Interv] 2021 May 01; Vol. 97 (6), pp. 1162-1173. Date of Electronic Publication: 2020 Sep 02.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 100884139 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1522-726X (Electronic) Linking ISSN: 15221946 NLM ISO Abbreviation: Catheter Cardiovasc Interv Subsets: MEDLINE

مواضيع طبية MeSH: Coronary Occlusion*/diagnostic imaging , Coronary Occlusion*/surgery , Percutaneous Coronary Intervention*/adverse effects, Aftercare ; Humans ; Patient Discharge ; Quality of Life ; Registries ; Treatment Outcome

المؤلفون: Marso SP; Cardiovascular Service Line, HCA Midwest Health, Kansas City, MO 64132, USA. Electronic address: Steve.Marso@HCAHealthcare.com.

المصدر: Interventional cardiology clinics [Interv Cardiol Clin] 2021 Jan; Vol. 10 (1), pp. xv-xxiii. Date of Electronic Publication: 2020 Oct 29.

نوع المنشور: Editorial

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101615153 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-7466 (Electronic) Linking ISSN: 22117458 NLM ISO Abbreviation: Interv Cardiol Clin Subsets: MEDLINE

مواضيع طبية MeSH: Coronary Occlusion* , Percutaneous Coronary Intervention*, Humans

المؤلفون: Heller S; Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK., Lingvay I; Department of Internal Medicine and Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, Texas, USA., Marso SP; HCA Midwest Health Heart and Vascular Institute, Overland Park, Kansas, USA., Philis-Tsimikas A; Scripps Whittier Diabetes Institute, San Diego, California, USA., Pieber TR; Department of Internal Medicine, Medical University of Graz, Graz, Austria., Poulter NR; Imperial Clinical Trials Unit, National Heart and Lung Institute, Imperial College London, London, UK., Pratley RE; AdventHealth Translational Research Institute, Orlando, Florida, USA., Hachmann-Nielsen E; Novo Nordisk A/S, Søborg, Denmark., Kvist K; Novo Nordisk A/S, Søborg, Denmark., Lange M; Novo Nordisk A/S, Søborg, Denmark., Moses AC; Novo Nordisk A/S, Søborg, Denmark.; Independent consultant, Novo Nordisk A/S, Portsmouth, New Hampshire, USA., Andresen MT; Novo Nordisk A/S, Søborg, Denmark., Buse JB; University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.

مؤلفون مشاركون: DEVOTE Study Group

المصدر: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2020 Dec; Vol. 22 (12), pp. 2241-2247. Date of Electronic Publication: 2020 Jul 09.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2*/complications , Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/epidemiology , Hypoglycemia*/chemically induced , Hypoglycemia*/epidemiology, Humans ; Hypoglycemic Agents/adverse effects ; Insulin Glargine/adverse effects ; Insulin, Long-Acting/adverse effects

المؤلفون: Heller S; Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK., Lingvay I; Department of Internal Medicine and Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, Texas, USA., Marso SP; HCA Midwest Health Heart and Vascular Institute, Overland Park, Kansas, USA., Philis-Tsimikas A; Scripps Whittier Diabetes Institute, San Diego, California, USA., Pieber TR; Department of Internal Medicine, Medical University of Graz, Graz, Austria., Poulter NR; Imperial Clinical Trials Unit, Imperial College London, London, UK., Pratley RE; AdventHealth Translational Research Institute, Orlando, Florida, USA., Hachmann-Nielsen E; Novo Nordisk A/S, Søborg, Denmark., Kvist K; Novo Nordisk A/S, Søborg, Denmark., Lange M; Novo Nordisk A/S, Søborg, Denmark., Moses AC; Novo Nordisk A/S, Søborg, Denmark.; Independent Consultant, Portsmouth, New Hampshire, USA., Trock Andresen M; Novo Nordisk A/S, Søborg, Denmark., Buse JB; University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.

مؤلفون مشاركون: DEVOTE Study Group

المصدر: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2020 Dec; Vol. 22 (12), pp. 2248-2256.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2*/complications , Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/epidemiology , Hypoglycemia*/chemically induced , Hypoglycemia*/epidemiology, Glycated Hemoglobin/analysis ; Humans ; Hypoglycemic Agents/adverse effects ; Insulin Glargine ; Risk Factors